pI: 9.5402 |
Length (AA): 182 |
MW (Da): 20872 |
Paralog Number:
1
Signal peptide: N | GPI Anchor: N | Predicted trans-membrane segments: 0
Targets have been classified into druggability groups (DG) according to their druggability score in network driven prioritizations. DGs range from 1 to 5; the higher the group number, the higher the chance of the target to be druggable
Modbase 3D models:
PDB Structures:
Ortholog group members (OG5_130909)
Species | Accession | Gene Product |
---|---|---|
Brugia malayi | Bm1_55035 | Ubiquitin-conjugating enzyme family protein |
Caenorhabditis elegans | CELE_Y69H2.6 | Protein UBC-19 |
Cryptosporidium hominis | Chro.20031 | hypothetical protein |
Cryptosporidium parvum | cgd2_240 | ubiquitin-conjugating enzyme |
Dictyostelium discoideum | DDB_G0278075 | hypothetical protein |
Drosophila melanogaster | Dmel_CG16894 | CG16894 gene product from transcript CG16894-RA |
Drosophila melanogaster | Dmel_CG10536 | crossbronx |
Echinococcus granulosus | EgrG_000156800 | AKT interacting protein |
Echinococcus multilocularis | EmuJ_000156800 | AKT interacting protein |
Homo sapiens | ENSG00000166971 | AKT interacting protein |
Loa Loa (eye worm) | LOAG_01487 | hypothetical protein |
Mus musculus | ENSMUSG00000031667 | thymoma viral proto-oncogene 1 interacting protein |
Neospora caninum | NCLIV_024020 | ubiquitin-conjugating enzyme domain-containing protein, putative |
Plasmodium berghei | PBANKA_1457000 | ubiquitin-conjugating enzyme E2, putative |
Plasmodium falciparum | PF3D7_1243700 | ubiquitin-conjugating enzyme E2, putative |
Plasmodium knowlesi | PKNH_1463000 | ubiquitin-conjugating enzyme E2, putative |
Plasmodium vivax | PVX_101085 | ubiquitin-conjugating enzyme E2, putative |
Plasmodium yoelii | PY01211 | ubiquitin-conjugating enzyme e2-17 kDa |
Schmidtea mediterranea | mk4.000287.01 | |
Toxoplasma gondii | TGME49_264050 | ubiquitin-conjugating enzyme subfamily protein |
Trichomonas vaginalis | TVAG_476010 | fused toes, putative |
Trichomonas vaginalis | TVAG_130740 | ubiquitin-conjugating enzyme E2, putative |
Gene/Ortholog | Organism | Phenotype | Source Study |
---|---|---|---|
PBANKA_1457000 | Plasmodium berghei | Dispensable | plasmo |
TGME49_264050 | Toxoplasma gondii | Probably essential | sidik |
wormbase | C. elegans RNAi experiments | WormBase web site, http://www.wormbase.org, release WS170 |
gerdes | Experimental determination and system-level analysis of essential genes in E. coli MG1655 | Gerdes et al., J Bacteriol. 2003 185:5673-84 |
yeastgenome | Systematic deletion of yeast genes | Saccharomyces Genome Database |
shigen | Profiling of E. coli Chromosome (PEC) | National Institute of Genetics, Japan |
blattner | Systematic mutagenesis of the E. coli (MG1655) genome | J Bacteriol 2004, 186:4921-4930 |
nmpdr | Genome-scale essentiality datasets from published studies (M. tuberculosis) | National Microbial Pathogen Data Resource |
keio | Systematic single-gene knock-out mutants of E. coli K12 | The Keio Collection |
neb | C. elegans RNAi phenotypes | Data obtained from Wormbase WS150, curated by K. Chaudary and T. Carlow, New England Biolabs |
alsford | High-throughput phenotyping using parallel sequencing of RNA interference targets in the African trypanosome | Genome Res 2011, 21:915-924 |
In TDR Targets, information about phenotypes that are caused by drugs, or by genetic manipulation of cells (e.g. gene knockouts or knockdowns) is manually curated from the literature. These descriptions help to describe the potential of the target for drug development. If no information is available for this gene or if the information is incomplete, this may mean that i) the papers containing this information either appeared after the curation effort for this organism was carried out or they were inadvertently missed by curators; or that ii) the curation effort for this organism has not yet started.
In any case, if you have information about papers containing relevant validation data for this target, please contact us.